Importation Of Italian-authorized Cisatracurio Hikma 2 Mg/ml Ampoules Due To The Current Shortage Of Canadian-authorized Cisatracurium Omega

Recall Summary Health Canada has authorized the temporary importation of Italian-made Cisatracurio Hikma 2 mg/mL ampoules to address a shortage of the Canadian-authorized version of this drug. The Italian product is being brought in because of packaging and supply concerns with the regular Canadian supply. This authorization applies across Canada.

Product
Cisatracurio Hikma 2 mg/mL Ampoules
Reason
Packaging - Product safety - Supply
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2024-04-24
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7a84e6b2-9761-491c-96a4-10adddba3368